Intest Res Search

CLOSE


Previous issues

  • HOME
  • BROWSE ARTICLES
  • Previous issue
Volume 20(4); Oct 2022
Editorial
Close layer
prev next
Reviews
Miscellaneous
Involvement of the cannabinoid system in chronic inflammatory intestinal diseases: opportunities for new therapies
Priscila A. Lima, Bárbara B. Berg, Marina Gomes Miranda e Castor
Intest Res. 2022;20(4):392-417.   Published online May 31, 2022
Full text    PubReader    ePub    PDF    
Close layer
prev next
IBD
Natural history of inflammatory bowel disease: a comparison between the East and the West
Eun Mi Song, Suk-Kyun Yang
Intest Res. 2022;20(4):418-430.   Published online December 2, 2021
Full text    PubReader    ePub    PDF    
Close layer
prev next
Statement
Korean Association for the Study of Intestinal Diseases guidance for clinical practice of adult inflammatory bowel disease during the coronavirus disease 2019 pandemic: expert consensus statements
Yong Eun Park, Yoo Jin Lee, Ji Young Chang, Hyun Joo Song, Duk Hwan Kim, Young Joo Yang, Byung Chang Kim, Jae Gon Lee, Hee Chan Yang, Miyoung Choi, Seong-Eun Kim, Seung-Jae Myung
Intest Res. 2022;20(4):431-444.   Published online January 5, 2022
Full text    PubReader    ePub    PDF    
Close layer
prev next
Original Articles
Efficacy of hepatitis B vaccination in patients with ulcerative colitis: a prospective cohort study
Anurag Mishra, Amarender Singh Puri, Sanjeev Sachdeva, Ashok Dalal
Intest Res. 2022;20(4):445-451.   Published online February 8, 2022
Full text    PubReader    ePub    PDF    
Close layer
prev next
Physician education can minimize inappropriate steroid use in patients with inflammatory bowel disease: the ACTION study
Yehyun Park, Chang Hwan Choi, Hyun Soo Kim, Hee Seok Moon, Do Hyun Kim, Jin Ju Kim, Dennis Teng, Dong Il Park
Intest Res. 2022;20(4):452-463.   Published online March 11, 2022
Full text    PubReader    ePub    PDF    Supplementary Material
Close layer
prev next
Long-term clinical and real-world experience with Crohn’s disease treated with anti-tumor necrosis factor-α antibodies
Haruka Otake, Satohiro Matsumoto, Hirosato Mashima
Intest Res. 2022;20(4):464-474.   Published online March 31, 2022
Full text    PubReader    ePub    PDF    
Close layer
prev next
Clinical features of very early-onset inflammatory bowel disease in Japan: a retrospective single-center study
Masaaki Usami, Ichiro Takeuchi, Reiko Kyodo, Yuri Hirano, Kosuke Kashiwagi, Hiroki Fujikawa, Hirotaka Shimizu, Toshinao Kawai, Katsuhiro Arai
Intest Res. 2022;20(4):475-481.   Published online June 13, 2022
Full text    PubReader    ePub    PDF    
Close layer
prev next
Gastrointestinal bleeding risk of non-vitamin K antagonist oral anticoagulants versus warfarin in general and after polypectomy: a population-based study with propensity score matching analysis
Jong Yop Pae, Eun Soo Kim, Sung Kook Kim, Min Kyu Jung, Jun Heo, Jang Hoon Lee, Min Ae Park
Intest Res. 2022;20(4):482-494.   Published online April 15, 2022
Full text    PubReader    ePub    PDF    Supplementary Material
Close layer
prev next
IBD
Abdominal aortic calcification in patients with inflammatory bowel disease: does anti-tumor necrosis factor α use protect from chronic inflammation-induced atherosclerosis?
Aikaterini Mantaka, Nikolaos Galanakis, Dimitrios Tsetis, Ioannis E. Koutroubakis
Intest Res. 2022;20(4):495-505.   Published online August 8, 2022
Full text    PubReader    ePub    PDF    
Close layer
prev next
Brief Communication
Novel inflammatory bowel disease (IBD) specific electronic medical record allows scalable auditing of IBD severity, therapy and complications to show the current unmet need in IBD care
Alex Barnes, David Carter, Patricia Kaazan, Alissa Walsh, Susan Connor, Jane M Andrews
Intest Res. 2022;20(4):506-508.   Published online April 26, 2022
Full text    PubReader    ePub    PDF    
Close layer
prev next
Letter to the Editor
Urinary chitinase 3-like 1 and intestinal fatty-acid binding proteins are not elevated in children with inflammatory bowel disease
Shaun Siong Chung Ho, Jacqueline Ilene Keenan, Andrew Stewart Day
Intest Res. 2022;20(4):509-513.   Published online July 22, 2022
Full text    PubReader    ePub    PDF    
Close layer
prev next
  • Journal Impact Factor 4.9
  • SCImago Journal & Country Rank
  • AOCC 2018
  • CSIBD
  • JSIBD
  • kasid
  • TSIBD
  • CCF
  • PubMed Central
  • PubMed
  • KoreaMed
  • KoMCI
  • Scopus
  • Directory of Open Access Journals (DOAJ)
  • GoogleScholar
  • EBSCO
  • Similarity Check
  • Crossref Cited-by Linking
  • CrossMark
  • Funder Registry
  • ORCID
  • COPE
  • KOFST
  • TrendMD


ABOUT
ARTICLE & TOPICS
Article Category

Browse all articles >

TOPICS

Browse all articles >

BROWSE ARTICLES
EDITORIAL POLICY
AUTHOR INFORMATION
Editorial Office
Room 310, Lotte Gold Rose II, 31 Seolleung-ro 86-gil, Gangnam-gu, Seoul 06193, Korea
Tel: +82-2-957-6145    Fax: +82-2-957-6146    E-mail: thekasid@irjournal.org                

Copyright © 2024 by Korean Association for the Study of Intestinal Diseases.

Developed in M2PI

Close layer
prev next